|
ATGA0499-50ul
|
NKMax Bio (ATGen)
|
HA Tag [AT5E7], Mouse Monoclonal Antibody
|
|
ELISA, WB
|
|
|
ATGA0395-100ul
|
NKMax Bio (ATGen)
|
Myc tag [AT19B4], Mouse Monoclonal Antibody
|
Human
|
ELISA, WB
|
|
|
ATGA0395-50ul
|
NKMax Bio (ATGen)
|
Myc tag [AT19B4], Mouse Monoclonal Antibody
|
Human
|
ELISA, WB
|
|
|
ATGP1585-250ug
|
NKMax Bio (ATGen)
|
VRK3 [1-474 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
|
ATGP1585-50ug
|
NKMax Bio (ATGen)
|
VRK3 [1-474 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
|
GTX11214
|
GeneTex International Corporation
|
pan Cytokeratin [PCK-26] (FITC), Mouse Monoclonal Antibody
|
Human, Mouse, Rat, Rabbit, Goat, Sheep, Bovine, Cat, Dog, Hamster, Chicken, Guinea pig, Pig, Carp, Lizard, Snake
|
IHC-Fr, IHC-P
|
|
|
GTX20459
|
GeneTex International Corporation
|
Bacterial Luciferase (FITC), Rabbit Polyclonal Antibody
|
|
FACS, IM
|
|
|
GTX30624
|
GeneTex International Corporation
|
KSHV LANA2 [CM-A807], Mouse Monoclonal Antibody
|
Kaposi's sarcoma-associated herpesvirus
|
ELISA, ICC/IF, IHC-Fr, IHC-P, IP, WB
|
|
|
HY-100064-10mg
|
MedChemexpress LLC
|
O-Desmethyl gefitinib [CAS 847949-49-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-100064-25mg
|
MedChemexpress LLC
|
O-Desmethyl gefitinib [CAS 847949-49-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-100064-5mg
|
MedChemexpress LLC
|
O-Desmethyl gefitinib [CAS 847949-49-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-100064-50mg
|
MedChemexpress LLC
|
O-Desmethyl gefitinib [CAS 847949-49-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-101117-10mg
|
MedChemexpress LLC
|
EED226 [CAS 2083627-02-3]
|
|
Cancer-programmed cell death
|
|
|
HY-101117-100mg
|
MedChemexpress LLC
|
EED226 [CAS 2083627-02-3]
|
|
Cancer-programmed cell death
|
|
|
HY-101117-25mg
|
MedChemexpress LLC
|
EED226 [CAS 2083627-02-3]
|
|
Cancer-programmed cell death
|
|
|
HY-101117-5mg
|
MedChemexpress LLC
|
EED226 [CAS 2083627-02-3]
|
|
Cancer-programmed cell death
|
|
|
HY-101117-50mg
|
MedChemexpress LLC
|
EED226 [CAS 2083627-02-3]
|
|
Cancer-programmed cell death
|
|
|
HY-10130-10mg
|
MedChemexpress LLC
|
Veliparib (dihydrochloride) [CAS 912445-05-7]
|
|
Cancer-programmed cell death
|
|
|
HY-10130-100mg
|
MedChemexpress LLC
|
Veliparib (dihydrochloride) [CAS 912445-05-7]
|
|
Cancer-programmed cell death
|
|
|
HY-10130-200mg
|
MedChemexpress LLC
|
Veliparib (dihydrochloride) [CAS 912445-05-7]
|
|
Cancer-programmed cell death
|
|
|
HY-10130-5mg
|
MedChemexpress LLC
|
Veliparib (dihydrochloride) [CAS 912445-05-7]
|
|
Cancer-programmed cell death
|
|
|
HY-10130-50mg
|
MedChemexpress LLC
|
Veliparib (dihydrochloride) [CAS 912445-05-7]
|
|
Cancer-programmed cell death
|
|
|
HY-101336-10mg
|
MedChemexpress LLC
|
RS 17053 hydrochloride [CAS 169505-93-5]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-101336-100mg
|
MedChemexpress LLC
|
RS 17053 hydrochloride [CAS 169505-93-5]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-101336-5mg
|
MedChemexpress LLC
|
RS 17053 hydrochloride [CAS 169505-93-5]
|
|
Metabolism-protein/nucleotide metabolism
|
|
